XTL Biopharmaceuticals Ltd. - ADR (XTLB)
Market Closed
15 Oct, 08:00 PM
$
1. 91
+0.03
+1.5957%
Pre Market
$
+0.22 +11.5183% 2. 13
1.87M Market Cap
- P/E Ratio
- Div Yield
7,428 Volume
0 Eps
$ 1.88
Previous Close Want to track XTLB and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
XTL Biopharmaceuticals Ltd. - ADR (XTLB) Statistics
Valuation metrics
Market Cap 1.87M
Enterprise value 5.14M
Trailing P/E (ttm) -0.65
Forward P/E -
PEG ratio 0.01
Price/Sales (ttm) 11.38
Price/Book (mrq) -18.45
Enterprise Value/Revenue 11.76
Enterprise Value/EBITDA -4.06
Overview
Shares outstanding -
Float -
Shares short -
% Held by insiders -
% Held by institutions -
Average volume (10 days) 14.44K
Average volume (90 days) 8.24K
Price summary
52-Week low 1.86
52-Week high 5.64
Beta -
50-Day moving average 2.38
200-Day moving average 2.61
Dividends and splits
Forward annual dividend rate -
Forward annual dividend yield -
Trailing annual dividend rate -
Trailing annual dividend yield -
5-Year annual dividend yield -
Payout ratio -
Dividend Date -
Ex-Dividend Date -
Last split factor 1:4
Last split Date 25 Mar 2026
Financials
Fiscal year
Fiscal year ends -
Most recent quarter (mrq) -
Profitability
Profit margin -10.64%
Operating margin -14.71%
Operational effectiveness
Return on assets -41.98%
Return on equity -2.69%
Income Statement
Revenue (ttm) -
Revenue per share (ttm) 0.06
Quarterly revenue growth (yoy) -
Gross profit (ttm) -
EBITDA -
Net income to common (ttm) -
Diluted EPS (ttm) -0.78
Quarterly earnings growth (yoy) -
Balance Sheet
Total cash (mrq) -
Total cash per share (mrq) 0.02
Total debt (mrq) -
Total Debt/Equity (mrq) -1.06
Current ratio (mrq) 0.4%
Book value per share (mrq) -0.03
Cash Flow
Cash flow statement -
Levered free cash flow (LFCF) -
2026 © Marketlog. All Rights Reserved.
